跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,818 条关于
“OncLive”
全部
1,818
临床试验
1,650
药物
9
机构
5
资讯
154
去年
Recent FDA Approvals and Clinical Trial Updates in Oncology Highlighted on OncLive On Air
去年
Precision Medicine Advances in Oncology: Targeted Therapies Show Promise in Multiple Cancers
去年
Adjuvant Ribociclib Approved for HR+/HER2- Early Breast Cancer, Offering New Hope for High-Risk Patients
2年前
Novel Chemotherapy-Free Regimens Show Promise in Mantle Cell Lymphoma
2年前
Camrelizumab Plus Rivoceranib Shows Sustained Survival Benefit in Unresectable HCC
2年前
Elevar Therapeutics Plans NDA Resubmission for Rivoceranib/Camrelizumab in Unresectable HCC After CRL
2年前
Abemaciclib Monotherapy Fails to Show Efficacy in Advanced Renal Cell Carcinoma
2年前
HS-20093 Shows Promise in Pretreated Extensive-Stage Small Cell Lung Cancer
2年前
Cabozantinib/Nivolumab Shows Consistent Benefits in RCC, Except for Favorable-Risk Group
去年
Saruparib Shows Promise as Selective PARP1 Inhibitor in Advanced Solid Tumors
第 1 页,共 16 页
上一页
下一页